Results with novel FXI inhibitor in AF set the stage for phase 3 trials
Christian Ruff, MD
Marco Valgimigli, MD, PhD
Linda Joosten, MD
Paulus Kirchhof, MD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.